Introduction {#sec1}
============

The number of confirmed coronavirus disease 2019 (COVID-19) cases around the globe is growing dramatically by the minute. Although the reason behind this uptick is chiefly due to the high contagiousness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it also is a result of increased testing. The reference standard diagnosis is currently based on real-time reverse transcription PCR (RT-PCR) of respiratory specimens, most commonly using nasopharyngeal swabs. However, as of this writing, no diagnostic method has yet exhibited perfect sensitivity, with testing often leading to false-negative results and delayed diagnosis \[[@bib1],[@bib2]\].

Case report {#sec2}
===========

We report the case of a 47-year-old man with no relevant medical history who sought care at our tertiary-care hospital with spiking fever. Onset of symptoms was a week earlier, with the patient\'s fever temperature ranging 37.5°C to 39.5°C. He reported myalgia and asthenia but denied having any upper or lower respiratory symptoms. However, the patient had been in contact with a confirmed COVID-19 case 10 days before his hospitalization, although his household remained asymptomatic.

At admission the patient had a temperature of 40°C and an oxygen saturation of 97% on ambient air without any need for oxygen supplementation; there was no dyspnoea, cough or haemodynamic instability. His physical examination revealed bibasilar crackles.

Initial laboratory results showed no significant alterations except for an elevated C-reactive protein at 30.6 mg/L and procalcitonin at 0.14 μg/L. Leucocyte count and differential were within normal limits ([Table 1](#tbl1){ref-type="table"} ).Table 1Initial laboratory results at admissionTable 1TestUnitValue at admissionReference valueHaemoglobing/dL15.713--17White blood cellsμL of blood61004000--9000White blood cell differential%62.3% neutrophils, 32.1% lymphocytes50--78% neutrophils, 20--45% lymphocytesPlateletsμL of blood135 000[a](#tbl1fna){ref-type="table-fn"}150 000--400 000Creatinineμmol/L10458--110Blood urea nitrogenmmol/L10.3[a](#tbl1fna){ref-type="table-fn"}2.5--7.5C-reactive proteinmg/L30.6[a](#tbl1fna){ref-type="table-fn"}\<3.5Procalcitoninμg/L0.14[a](#tbl1fna){ref-type="table-fn"}\<0.1Ferritinμg/L75330--400Lactase dehydrogenaseU/L309[a](#tbl1fna){ref-type="table-fn"}120--246LipaseU/L23023--300[^1]

A chest computed tomographic scan revealed several well-circumscribed central and peripheral ground-glass opacities associated with vascular ectasia, highly suggestive of a viral bilateral pneumonia, and particularly a COVID-19--related pneumonia, in view of the raging pandemic \[[@bib3],[@bib4]\]. The index of severity was estimated at 5/25 \[[@bib5]\]. There was no pleural or pericardiac effusion. A few lymph nodes less than 1 cm in size were noted in the mediastinum ([Fig. 1](#fig1){ref-type="fig"} ).Fig. 1Axial view of chest CT scan revealing bilateral ground-glass opacities (arrows) indicating COVID-19 pneumonia. COVID-19, coronavirus disease 2019; CT, computed tomography.Fig. 1

Therapy with hydroxychloroquine and azithromycin was then empirically initiated while awaiting the SARS-CoV-2 RT-PCR results conducted using nasopharyngeal swabs.

The results of the first nasopharyngeal SARS-CoV-2 RT-PCR testing \[[@bib6]\] conducted on day 7 of symptoms were negative. The test was repeated 2 days later with the same result.

Given the high index of suspicion of COVID-19 despite the two negative initial nasopharyngeal RT-PCR results, a bronchoscopy was performed the following day (day 10 after symptom onset); RT-PCR testing was done on the bronchoalveolar lavage sample. The latter was positive for SARS-CoV-2, confirming our suspected diagnosis of COVID-19 pneumonia.

Multiplex RT-PCR testing using the BioFire FilmArray technique \[[@bib7]\] on the bronchoalveolar lavage sample was negative for other common respiratory viruses (wild coronavirus subtypes HKU1, NL63, 229E and OC43), adenovirus, rhinovirus, enterovirus, influenza A (H1, H3, H1-2009), influenza B, parainfluenza 1/2/3/4, human metapneumovirus and respiratory syncytial virus and bacteria (*Bordetella pertussis, Chlamydophila pneumoniae, Mycoplasma pneumoniae*). Culturing the bronchoalveolar lavage sample yielded no microbial growth.

Lopinavir and ritonavir were then added to the patient\'s treatment regimen following local institutional COVID-19 treatment guidelines.

The patient\'s disease course progressed clinically well without the need for mechanical ventilation. However, his C-reactive protein increased to 53.8 mg/L during his hospitalization, and ceftriaxone was added to treat a likely bacterial secondary infection. Only one fever spike (temperature 39.5°C) occurred the following day; he remained apyretic for the rest of his hospital stay.

The patient\'s hospitalization in our COVID-19 unit was uncomplicated, and he was discharged on day 7 of hospitalization with instructions to remain in strict home confinement. The SARS-CoV-2 RT-PCR using nasopharyngeal swab was repeated on days 24 and 29 after symptom onset, following the US Centers for Disease Control and Prevention\'s guidelines on discontinuation of isolation \[[@bib8]\]. Both test results were negative.

Discussion {#sec3}
==========

Daily medical practice commonly focuses on expertise and clinical judgement to guide diagnosis and treatment. With the coronavirus pandemic hitting hospitals around the globe, physicians must remain alert and maintain a high index of suspicion when it comes to COVID-19 \[[@bib9]\].

Studies have found RT-PCR to have an imperfect sensitivity, estimated to be around 63% for nasopharyngeal sampling \[[@bib10]\]. The disparity in results could be due to low virus shedding in the upper respiratory tract early on, damaged specimen (as with heat exposure) \[[@bib11]\] or inappropriate sample collection. A combination of clinical presentation and radiologic evidence can help dodge underdiagnosis \[[@bib12]\]. Chest computed tomographic scan has a higher sensitivity in detecting COVID-19 compared to RT-PCR \[[@bib13]\], even in paucisymptomatic patients, but it has low specificity \[[@bib14]\], as the imaging pattern could be similar in non--coronavirus-associated viral pneumonia.

Because virologic evidence of SARS-CoV-2 is required to confirm diagnosis of COVID-19, repeat testing using RT-PCR is indicated, preferably via deeper specimen collection, such as sputum or bronchoalveolar lavage \[[@bib10],[@bib15]\], if initial results are negative in cases of high clinical, epidemiologic or radiologic suspicion.

Conclusion {#sec4}
==========

When a clinician strongly suspects a COVID-19--related infection but faces negative RT-PCR results, it is critical to perform repeat testing for SARS-CoV-2, preferably using deep respiratory specimens, such as bronchoalveolar lavage. While RT-PCR remains the reference standard for diagnosis, a negative result should be interpreted with a grain of salt. Its negative predictive value is based on pretest probability. Combining several diagnostic tests would increase the diagnostic accuracy. When in doubt, testing should be repeated, especially when a high index of suspicion for SARS-CoV-2 persists.
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